This product is not for use by or sale to persons under the age of 18. This product should be used only as directed on the label. It should not be used if you are pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. A Doctor’s advice should be sought before using this and any supplemental dietary product. All trademarks and copyrights are property of their respective owners and not affiliated with nor do they endorse this product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. By using this site you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited By Law.
Unfortunately the availability of only CBD isolate medically is a direct consequence of the 1920’s prohibition campaign that outlawed cannabis medications, despite the fact that prior to prohibition cannabis was listed in the United States pharmacopeia as a valuable medication in the treatment of over 100 separate medical conditions. It is still illegal to market THC in cannabis medications despite its known efficacy.

It’s thought that CBD might affect your health by attaching to receptors in the body’s endocannabinoid system—a complex biological system involved in maintaining certain aspects of your health. Emerging research shows that endocannabinoids may play a role in regulating such functions as memory, sleep, and mood, as well as metabolic processes like energy balance. In addition, CBD oil may play a role in improving a variety of health conditions.
CBD shows promise in the treatment of anxiety disorders, according to a report published in the journal Neurotherapeutics in 2015. Looking at results from experimental research, clinical trials, and epidemiological studies, the report’s authors found evidence that CBD may help treat generalized anxiety disorder, panic disorder, social anxiety disorder, obsessive-compulsive disorder, and post-traumatic stress disorder. However, the authors caution that human-based research on CBD and anxiety is fairly limited at this point.
It has proved to be pretty useless at treating anything apart from limited success with Multiple sclerosis (MS)spasticity and even then the results are not impressive. As early as October 2014, NICE published guidance on the management of MS and said that the substantial cost of Sativex “compared to the modest benefit” did not justify its use. Paying for it privately will cost you about £350 a month.
×